Hims & Hers Health, Inc. (HIMS)

Healthcare · Drug Manufacturers Specialty Generic · NYSE

Hims & Hers Health, Inc. (HIMS) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $7.31B, a trailing price-to-earnings ratio of 52.6 and a free-cash-flow yield of 0.7%. Over the most recent reported fiscal year, revenue grew 59.0% and free cash flow per share fell 73.5%.

Market cap	$7.31B
Trailing P/E	52.6
FCF yield	0.7%
Revenue growth (YoY)	+59.0%
EPS growth (YoY)	+16.3%
FCF/share growth (YoY)	-73.5%
Exchange	NYSE
Sector	Healthcare
Industry	Drug Manufacturers Specialty Generic

Explore live HIMS data on Nama Insights →

Recent Congressional trades

Hims & Hers Health, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Lisa McClain	House	Buy	$1,001 - $15,000	Aug 13, 2025